Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the humanized anti-soluble aggregated amyloid-beta (A?) monoclonal antibody "LEQEMBI®" has been ...
Sichuan Liangshan Meigu Shamanaito Phase II Wind Farm is a 230MW onshore wind power project. It is planned in Sichuan, China. According to GlobalData, who tracks and profiles over 170,000 power plants ...